Navigation Links
Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
Date:4/20/2012

EAST BRUNSWICK, N.J., April 20, 2012 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that the Company's first quarter financial results will be released prior to the open of the market on Wednesday, May 9, 2012.
Savient executive management will host a conference call beginning at 9:00 a.m. Eastern Time on May 9, 2012, to discuss these results and to answer questions.

To participate by telephone, please dial 866-393-1565 (Domestic) or 253-237-1151 (International). The conference ID number is 72346185.  The live and archived webcast can be accessed on the investor relations section of the Savient website at www.savient.com.  A telephone replay will be available from 12:00 p.m. Eastern Time on May 9, 2012, through 12:00 a.m. Eastern Time on May 16, 2012, by dialing 855-859-2056 (Domestic) or 404-537-3406 (International) and entering conference ID number 72346185.

ABOUT SAVIENT PHARMACEUTICALS, INC.Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA® (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University ("Duke") and Mountain View Pharmaceuticals, Inc. ("MVP"). Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents disclosing and claiming the licensed technology and, in addition, Savient owns or co-owns U.S. and foreign patents and patent applications, which collectively form a broad portfolio of patents covering the composition, manufacture and methods of use and administration of KRYSTEXXA. Savient also manufactures and supplies Oxandrin® (oxandrolone tablets, USP) CIII in the U.S. For more information, please visit the Company's website at www.savient.com.

SVNT-IContact: Mary Coleman

Carney Noensie Savient Pharmaceuticals, Inc.

Burns McClellan information@savient.com

cnoensie@burnsmc.com (732) 418-9300

(212) 213-0006


'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Savient Pharmaceuticals to Present at the Imperial Capital Healthcare Investor Forum
2. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2011 Results
3. Savient Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
4. Savient Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference
5. Savient Pharmaceuticals Appoints David Y. Norton Interim Chief Executive Officer
6. Savient Pharmaceuticals Appoints Experienced Pharmaceutical Executive, David Veitch as President of Savient Europe
7. Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA®
8. Savient Pharmaceuticals to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
9. Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
10. Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
11. Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... ... 18, 2019 , ... Uniform Advantage (UA), a leader in the ... Breast Cancer programs and services. , This year, more than 271,000 Americans will be ... the month of October 2019, Uniform Advantage will donate $5 for every unique use ...
(Date:9/17/2019)... , ... September 17, 2019 , ... Called Muss-Bits (Musical ... Company’s 2019 Innovation by Design Awards Students category. , It was developed by Associate ... Bioengineering Institute. , Muss-Bits is comprised of two parts. A “sensor bit” that can ...
(Date:9/17/2019)... Mass. (PRWEB) , ... September 17, 2019 , ... ... long-term care industry, announces today the launch of RegistryConnect , the first ... input of registry owners. RegistryConnect includes care-matching, schedule recording, client and caregiver relationship ...
Breaking Medicine Technology:
(Date:9/17/2019)... ... , ... Milwaukee-area dealership Hall Cars has hosted an annual event each fall for years in ... Out Cancer,” entails that for every vehicle purchased from Sept. 17 to Nov. 14, the ... 50 days, it has also been referred to as, “50 for 50.” , Though ...
(Date:9/17/2019)... ... September 17, 2019 , ... ... Keflezighi and the American Heart Association (AHA)-San Diego Chapter to raise awareness of ... Stroke Walk on Saturday, September 21 in Balboa Park alongside National University System ...
(Date:9/17/2019)... ... September 17, 2019 , ... Encouraging a spirit of ... Cole, Vice President of Insurance Plan Management for Dental Care Alliance, the 2019 ... (NADP) at their annual conference, CONVERGE 2019, in Orlando. This award commends exemplary ...
(Date:9/17/2019)... SAN MATEO, Calif. (PRWEB) , ... September 17, ... ... under the CE Mark for Europe and the 21st Century Cures Act in ... on spine surgery, radiology, and pain management. Using images from existing MRI ...
(Date:9/17/2019)... Ga. (PRWEB) , ... September 17, 2019 , ... ... social responsibility initiative contributing to the long-term health of canines – specifically golden ... of all Golden Retrievers will die from cancer – one out of five ...
Breaking Medicine News(10 mins):